Safety and immunogenicity of live attenuated human–bovine (UK) reassortant rotavirus vaccines with VP7-specificity for serotypes 1, 2, 3 or 4 in adults, children and infants
- 4 June 1999
- Vol. 17 (20-21) , 2715-2725
- https://doi.org/10.1016/s0264-410x(98)00497-6
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Review Of Rotavirus Vaccine Trials In FinlandThe Journal of Infectious Diseases, 1996
- Evaluation of the protective efficacy of a serotype 1 bovine-human rotavirus reassortant vaccine in infantsThe Pediatric Infectious Disease Journal, 1995
- Vaccination of Thai infants with rhesus-human reassortant tetravalent oral rotavirus vaccineThe Pediatric Infectious Disease Journal, 1994
- Evaluation of a Bovine-Human Rotavims Reassortant Vaccine in InfantsThe Journal of Infectious Diseases, 1993
- Field Trial of Rhesus Rotavirus or Human-Rhesus Rotavirus Reassortant Vaccine of VP7 Serotype 3 or 1 Specificity in InfantsThe Journal of Infectious Diseases, 1992
- Protective efficacy against serotype 1 rotavirus diarrhea by live oral rhesus-human reassortant rotavirus vaccines with human rotavirus VP7 serotype 1 or 2 specificityThe Pediatric Infectious Disease Journal, 1992
- Immunogenicity and safety of rhesus-human rotavirus reassortant vaccines with serotype 1 or 2 VP7 specificityVaccine, 1991
- Serotype 1 reassortant of bovine rotavirus WC3, strain WI79-9, induces a polytypic antibody response in infantsVaccine, 1990
- Human-Rhesus Reassortant Rotavirus Vaccines: Safety and Immunogenicity in Adults, Infants, and ChildrenThe Journal of Infectious Diseases, 1988
- Response of adult human volunteers to oral administration of bovine and bovine/human reassortant rotavirusesVaccine, 1986